Hospital Geral de Nova Iguacu

Nova Iguaçu, Rio de Janeiro 26030-381

0 studies enrolling now · 2 studies all time

What they study most

HIV-1, Human Immunodeficiency Virus

Studies at this site

• Prospective Observational Epidemiologic Study of Maraviroc's Safety — Completed
• A Phase 2B Multicenter, Randomized, Comparative Trial Of UK-453,061 Versus Etravirine In Combination With Darunavir/Ritonavir And A Nucleos(t)Ide Reverse Transcriptase Inhibitor For The Treatment Of Antiretroviral Experienced HIV-1 Infected Subjects With Evidence Of NNRTI Resistant HIV-1 — Stopped early